Search
-
Finance Home
-
Yahoo!
-
Help
[
Latest Headlines
|
Market Overview
|
News Alerts
]
GLAXOSMITHKLINE Company News
LSE:GSK.L
Enter symbol:
symbol lookup
More Info:
Quote
|
Chart
|
News
|
Profile
|
Reports
|
Research
Headlines by Date
Latest
Mar 2 - Apr 25
Oct 27, 2011 - Mar 1, 2012
Jul 15 - Oct 26
May 25, 2011 - Jul 14, 2011
(all times are US Eastern)
Friday, May 25, 2012
Europe stocks end week higher after choppy session
-
at MarketWatch
- 5:07 pm
Takeda chases emerging market sales with Brazil buy
-
at Reuters
- 12:14 pm
Glaxo Diabetes Drug Data Revealed Amid Hostile Takeover
-
at Bloomberg
- 12:01 am
Thursday, May 24, 2012
Google, Vegas Strip Steak, Microsoft, ABC: Intellectual Property
-
at Bloomberg
- 5:00 am
Glaxo Avoids Market for Lemons by Acquiring Its Collaborators
-
at Bloomberg
- 12:01 am
Wednesday, May 23, 2012
GSK to drop Human Genome bid if "poison pill" stands
-
Reuters
- 4:08 pm
GSK says amends Human Genome tender offer conditions
-
at Reuters
- 1:49 pm
Tuesday, May 22, 2012
Fake drugs threaten gains made in war on malaria
-
at Reuters
- 12:01 am
Monday, May 21, 2012
Auxilium Pharmaceuticals, Inc. to discuss the agreement for the Testim® U.S. co-promotion with GlaxoSmithKline LLC - Conference call Call scheduled for 10:00 am ET today
-
CCBN
- 3:00 pm
Auxilium, Glaxo to co-promote Testim in US
-
AP
- 2:44 pm
UPDATE 1-Auxilium, GSK to co-promote testosterone gel in US
-
at Reuters
- 12:59 pm
Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
-
PR Newswire
- 12:00 pm
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co-Promotion Agreement for Testim® in the U.S.
-
PR Newswire
- 12:00 pm
Friday, May 18, 2012
GSK melanoma drug shows promise in early trial
-
at Reuters
- 12:01 am
Thursday, May 17, 2012
Stopping Fake Drugs From Pakistan Is Too Late for Victims
-
at Bloomberg
- 11:02 pm
Human Genome board adopts 'poison pill' measure
-
AP
- 3:38 pm
Prestige Brands posts small fiscal 4Q loss
-
AP
- 3:00 pm
Human Genome in Talks With Potential Suitors
-
at Bloomberg
- 2:11 pm
Human Genome adopts rights as it wards off Glaxo
-
at Reuters
- 12:15 pm
RPT-Glaxo melanoma drug combo shows promise in small trial
-
at Reuters
- 11:59 am
Wednesday, May 16, 2012
Glaxo melanoma drug combo shows promise in small trial
-
at Reuters
- 11:04 pm
Glaxo’s Melanoma Cocktail Slows Cancer in Study
-
at Bloomberg
- 11:00 pm
GlaxoSmithKline closes on Theravance deal
-
AP
- 3:26 pm
GlaxoSmithKline Completes Transaction to Increase Its Ownership in Theravance
-
GlobeNewswire
- 2:17 pm
Tuesday, May 15, 2012
UPDATE 1-GSK pays 61 mln stg to take control of Cellzome
-
at Reuters
- 11:01 am
UK lawmakers urge action on medicine shortages
-
at Reuters
- 8:00 am
Friday, May 11, 2012
OncoMed Pharma files for IPO of up to $115 million
-
at Reuters
- 5:26 pm
UPDATE 1-OncoMed Pharma files for IPO of up to $115 mln
-
at Reuters
- 5:21 pm
Google’s Brin Makes Strides in Hunt for Parkinson’s Cure: Health
-
at Bloomberg
- 5:00 am
Thursday, May 10, 2012
Gilead’s Pill Wins U.S. Panel Backing to Prevent HIV
-
at Bloomberg
- 11:50 pm
GSK starts $2.6 bln tender offer for Human Genome
-
at Reuters
- 1:07 pm
Wednesday, May 9, 2012
Risk of Unprotected Sex Debated in Gilead HIV Pill Review
-
at Bloomberg
- 2:56 pm
Top Headlines: Glaxo Turns Hostile on Human Genome
-
at Bloomberg
- 12:15 pm
GSK to launch $2.6 billion Human Genome tender offer
-
Reuters
- 7:55 am
Glaxo goes hostile with offer for Human Genome
-
at MarketWatch
- 7:34 am
Glaxo to Begin Hostile Offer for Human Genome Sciences
-
at Bloomberg
- 7:07 am
Tuesday, May 8, 2012
Gilead HIV Pill Shown Safe in Studies, FDA Staff Report Says
-
at Bloomberg
- 2:00 pm
Friday, May 4, 2012
Bonds Resurrected as Glaxo Leads Rising Sales
-
at Bloomberg
- 5:06 pm
Thursday, May 3, 2012
UPDATE 1-Several arrested in US crackdown on drug thieves
-
at Reuters
- 11:51 pm
Dollar bond market lures European corporates
-
at Reuters
- 8:56 pm
GSK rejects idea of buying AstraZeneca
-
at Reuters
- 6:56 pm
Wednesday, May 2, 2012
New Issue-GlaxoSmithKline sells $5 bln notes in 3 parts
-
at Reuters
- 10:34 pm
GlaxoSmithKline Leads Borrowers Selling Most Debt Since March
-
at Bloomberg
- 10:13 pm
Biotech targets fight back as Big Pharma circles
-
Reuters
- 6:16 pm
ADR REPORT-Weak data again leads shares lower
-
at Reuters
- 5:46 pm
Tuesday, May 1, 2012
Estimated Dividend Yield Rankings of FTSE 100 Company
-
at Bloomberg
- 12:55 pm
INSIGHT-Cancer in Africa: Fighting a nameless enemy
-
at Reuters
- 9:47 am
Monday, Apr 30, 2012
Amarin up on Citi projections for cholesterol drug
-
AP
- 7:12 pm
Actelion Lung Drug Meets Main Goal in Pivotal Patient Study
-
at Bloomberg
- 6:24 am
Obesity-Linked Diabetes Tougher to Treat in Chindren
-
at Bloomberg
- 5:00 am
Sunday, Apr 29, 2012
GSK bid undervalues Human Genome, investor says
-
Reuters
- 4:44 pm
Glaxo Bid Undervalues Human Genome Sciences, Sunday Times Says
-
at Bloomberg
- 11:34 am
Friday, Apr 27, 2012
EU plans to block fake drugs spark industry row
-
at Reuters
- 2:50 pm
Thursday, Apr 26, 2012
FDA approves Votrient® for treatment of patients with certain types of advanced soft tissue sarcoma
-
PR Newswire
- 11:54 pm
UPDATE 1-US FDA approves Glaxo cancer drug Votrient
-
at Reuters
- 10:56 pm
Glaxo’s Votrient Gains U.S. Approval for Deadly Sarcomas
-
at Bloomberg
- 10:55 pm
U.S. Stock Options With Biggest Changes in Implied Volatility
-
at Bloomberg
- 4:30 pm
AstraZeneca CEO quits as drug sales tumble
-
Reuters
- 1:59 pm
FEATURE-Two new vaccines give Ghana hope for healthy growth
-
at Reuters
- 10:20 am
[
additional, older articles
]
Help
Copyright © 2012 Yahoo! Inc. All Rights Reserved.
Privacy Policy
-
Terms of Service
Questions or Comments?